43 results
DEF 14A
NMRA
Neumora Therapeutics Inc.
25 Apr 24
Definitive proxy
4:05pm
Strategy Officer at AbbVie, a public pharmaceutical company, where he was responsible for AbbVie’s corporate strategy, business development … through February 2022, Mr. Piacquad served as Senior Vice President, Business Development of Amgen where he was responsible for corporate strategy
10-K
2023 FY
NMRA
Neumora Therapeutics Inc.
7 Mar 24
Annual report
4:05pm
, and postural instability. PD patients lose dopamine-producing neurons in the substantia nigra, the region of the brain responsible for motor control … responsible for motor control. Approximately one million people in the United States have PD.
Preclinical Data
We have identified multiple small
10-K
EX-31.1
32hk2s
7 Mar 24
Annual report
4:05pm
10-K
EX-97.1
m981ufbs 8xc
7 Mar 24
Annual report
4:05pm
10-K
EX-31.2
xei5xafte358mh5303u
7 Mar 24
Annual report
4:05pm
10-Q
EX-31.1
x90m6chl
1 Nov 23
Quarterly report
4:05pm
10-Q
EX-31.2
fpnfs62nk7
1 Nov 23
Quarterly report
4:05pm
S-8
EX-99.1
qsre1wsm
19 Sep 23
Registration of securities for employees
9:57pm
S-8
EX-99.3
eqk9ump4g53va fn
19 Sep 23
Registration of securities for employees
9:57pm
8-K
EX-3.2
k5rawazd3ssw8
19 Sep 23
Amendments to Articles of Incorporation or Bylaws
4:16pm
424B4
ehur7 1m7vw0s4s60c
18 Sep 23
Prospectus supplement with pricing info
4:12pm
S-1/A
enep9
11 Sep 23
IPO registration (amended)
6:07am
S-1/A
EX-1.1
hfq zev0to
11 Sep 23
IPO registration (amended)
6:07am
S-1
EX-10.14
izf b5ksphe
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.7
x1xcial bgq
25 Aug 23
IPO registration
5:03pm
S-1
EX-3.3
9rbb6lv99eq4185m8
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.6
yd4o4qvrpdkfsyo1ub
25 Aug 23
IPO registration
5:03pm